drugset / Trial / NCT04046302

Vaginal Dinoprostone Administration Prior to an Intrauterine Device Insertion in Multiparous Women.

NCT04046302

Phase 4 Completed 160 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To investigate whether vaginal dinoprostone administered before intrauterine device (IUD) insertion reduces failed insertions, insertion-related complications, and pain in multiparous women.

Timeline

Start
2019-08-30
Primary completion
2020-01-10
Completion
2020-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other

Indications

No indication recorded.